Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta‐analysis of ten years' experience

@article{Appleby2007PsychiatricAN,
  title={Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta‐analysis of ten years' experience},
  author={B. Appleby and P. S. Duggan and A. Regenberg and P. Rabins},
  journal={Movement Disorders},
  year={2007},
  volume={22}
}
  • B. Appleby, P. S. Duggan, +1 author P. Rabins
  • Published 2007
  • Medicine, Psychology
  • Movement Disorders
  • Deep brain stimulation (DBS) has been approved by the FDA for use in the treatment of Parkinson's disease, essential tremor, and dystonia. Case reports and case series have reported significant psychiatric side effects in some individuals. The goal of this meta‐analysis is to characterize the risks and benefits of DBS and to assess its possible use within the psychiatric setting. A search was conducted on PubMed, EBSCO, and PsycInfo in January 2006 that covered the time period 1 Jan 1996–30 Dec… CONTINUE READING
    Mental Side Effects of Deep Brain Stimulation (DBS) for Movement Disorders: The Futility of Denial
    • 26
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 54 REFERENCES